Shares of inTEST Co. (NYSE:INTT – Get Free Report) were up 1.5% on Friday . The company traded as high as $8.56 and last traded at $8.56. Approximately 28,517 shares were traded during trading, a decline of 12% from the average daily volume of 32,471 shares. The stock had previously closed at $8.43.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on INTT shares. Northland Capmk raised inTEST from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 2nd. Northland Securities raised their price objective on inTEST from $13.00 to $16.00 and gave the company an “outperform” rating in a research report on Wednesday, January 8th.
Read Our Latest Report on INTT
inTEST Trading Up 1.5 %
Institutional Trading of inTEST
A number of institutional investors and hedge funds have recently modified their holdings of INTT. Royce & Associates LP increased its holdings in shares of inTEST by 9.9% in the 3rd quarter. Royce & Associates LP now owns 1,219,157 shares of the company’s stock worth $8,900,000 after purchasing an additional 110,078 shares in the last quarter. Bard Associates Inc. boosted its stake in shares of inTEST by 2.1% in the 3rd quarter. Bard Associates Inc. now owns 199,170 shares of the company’s stock worth $1,454,000 after buying an additional 4,105 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of inTEST in the 3rd quarter worth $120,000. Geode Capital Management LLC boosted its stake in shares of inTEST by 6.6% in the 3rd quarter. Geode Capital Management LLC now owns 131,106 shares of the company’s stock worth $957,000 after buying an additional 8,161 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of inTEST by 42.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 37,481 shares of the company’s stock worth $274,000 after buying an additional 11,102 shares during the last quarter. Institutional investors own 63.18% of the company’s stock.
inTEST Company Profile
inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Featured Articles
- Five stocks we like better than inTEST
- What Does a Stock Split Mean?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- 3 Warren Buffett Stocks to Buy Now
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Stock Splits, Do They Really Impact Investors?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for inTEST Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTEST and related companies with MarketBeat.com's FREE daily email newsletter.